OMX Ventures: A VC firm investing in the intersection of biology and computing.
Location
Lincolnshire, IL, US
Founded
2020
OMX Ventures is a venture capital firm that focuses on investing at the intersection of biology and computing. The firm typically participates in Seed, Series A, Series B, and Series D funding rounds, supporting innovative startups with investments that span various stages of development. OMX Ventures is dedicated to backing companies that leverage the convergence of biological sciences and computational technologies to drive transformative advancements.
Notable portfolio companies include Aperiam Bio, Delix Therapeutics, Finch Therapeutics, Freya Biosciences, Glyphic Biotechnologies, Matterworks, Mythic Therapeutics, Replay, and VedaBio. The firm prides itself on its deep expertise in both biology and computing, offering strategic guidance and support to its portfolio companies. Key partners and decision-makers at OMX Ventures bring a wealth of experience from leading institutions and successful ventures in the biotech and tech industries, ensuring that their investments are well-positioned for growth and innovation.
OMX Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
